Blood Flow Evaluation After Carotid Surgical Treatment
BEAT
1 other identifier
observational
40
0 countries
N/A
Brief Summary
Approximately 20% of strokes originate from the rupture of an atherosclerotic plaque in the carotid artery. Surgical revascularization, i.e. carotid endarterectomy (CEA), is the treatment of choice for patients with a symptomatic carotid stenosis each year about 3,000 procedures are performed in the Netherlands. Currently, two surgical procedures are performed in clinical practice. Most frequently an endarterectomy is performed using a length incision over the artery, followed by a patch plasty (CEAP), in order to reduce the risk of restenosis. As an alternative the eversion technique (ET) was introduced, in which transversal arteriotomy is performed and the plaque is removed from within. After reconstruction with a patch a \>50% restenosis has been described in 6-36% of patients during long-term follow-up. When using the eversion technique this is seen in 1.7-2.5%, while also the risk on adverse events seem to be lower. One of the drivers for atherosclerosis in general is a disturbance of local blood flow. This may lead to turbulence, recirculation and stasis of blood. The subsequent low Wall Shear Stress may lead to the ne formation of plaque that in turn may become instable and cause recurrent ischemic events. Recently, a breakthrough was achieved in the imaging options of flow in the carotid arteries, using Vector Flow Imaging. Using a fully programmable ultrasound machine, over 10,000 frames per second can be captured, in comparison to about 50 in regular ultrasound. This enables the tracking of particles that, after processing will provide the needed flow information. A recent study, comparing flow before and after CEAP has shown that there is significant recirculation after reconstruction. This raises the question whether this would be more optimal after ET, which would support the potential lower incidence of recurrent stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 14, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedAugust 5, 2025
August 1, 2025
4 months
February 10, 2025
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
2D spatio-temporal blood flow velocity profiles
2D vector velocity fields derived from the US-based flow images will be used to calculate the spatio-temporal blood flow velocities.
6-8 weeks after CEA
Secondary Outcomes (3)
Wall shear stress
6-8 weeks after CEA
Vortex identification
6-8 weeks after CEA
Vector complexity
6-8 weeks after CEA
Study Arms (2)
CEA with patch repair (CEAP)
Patients with a carotid artery stenosis that underwent recent conventional carotid endarterectomy with patch repair. Ultrasound measurements were performed 6-8 weeks after CEAP.
CEA with eversion technique (ET)
Patients with a carotid artery stenosis that underwent recent carotid endarterectomy with the eversion technique. Ultrasound measurements were performed 6-8 weeks after CEAP.
Interventions
Ultrasound-based flow imaging (based on blood speckle tracking) of the carotid artery will be acquired at 6-8 weeks after surgery.
Eligibility Criteria
Patients that underwent a CEA, without residual stenosis after surgery, will be included in this study. Patients with ET will be recruited in two collaborating hospitals (ETZ and MST) at the department of Vascular Surgery. Participants to the CAP-VALUE trial (Rijnstate and Radboud) are included, where already ultrasound measurements after CEAP were acquired.
You may qualify if:
- Presence of carotid artery stenosis (≥50%) according to conventional clinically performed imaging (duplex/CT(A)/MR(A)) for which patient underwent uncomplicated CEA with either a patch plasty or the eversion technique
- ≥18 years old;
- Able to provide signed or oral informed consent
- Carotid artery \<25mm below skin
You may not qualify if:
- Carotid bifurcation with depth of center bulb lumen ≥2.5cm
- Restenosis after carotid revascularisation at side of interest
- Participating in another clinical study, interfering on outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rijnstate Hospitallead
- Elisabeth-TweeSteden Ziekenhuiscollaborator
- Medisch Spectrum Twentecollaborator
- Radboud University Medical Centercollaborator
- University of Twentecollaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Michel M.P.J. Reijnen, MD, PhD
Rijnstate Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 14, 2025
Study Start
September 1, 2025
Primary Completion
December 31, 2025
Study Completion
April 1, 2026
Last Updated
August 5, 2025
Record last verified: 2025-08